Company news
Blinklab Limited (ASX:BB1) news
Blinklab Limited news releases on 6ix. Latest, Aug 4, 2026: European ADHD Study Delivers Positive Results
Press releases & updates
European ADHD Study Delivers Positive Results
August 4, 2026
2026 Annual Report & Appendix 4E
July 31, 2026
BlinkLab Secures A$17.5M to Launch Autism Diagnostic Aid
April 15, 2026
BlinkLab Launches Pivotal US FDA Trial for AI Smartphone Autism Diagnostic
March 24, 2026
Validation Program Commences-FDA 510(k) - First Participant
March 23, 2026
Morocco's Nationwide Government-Funded Autism Screening
March 22, 2026
Trading Halt
March 18, 2026
Clinical Trial Network for Pivotal FDA Study Complete
March 15, 2026
Half Yearly Report and Accounts
February 24, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 29, 2026
High-Profile Journal Publication Validates BB1 Technology
January 4, 2026
Appointment of Managing Director and Board Changes
December 17, 2025
Pilot Study Confirms High Diagnostic Accuracy & Readiness
October 21, 2025
2025 Annual Report & Appendix 4E
August 28, 2025
US Ethics Approval Received for the Main Phase of FDA510(k)
June 29, 2025
Response to ASX Price and Volume Query
June 24, 2025
Successful Placement of A$7.66M to Underpin Growth Strategy
May 1, 2025
BlinkLab Surpasses Key Milestone in Pivotal U.S. Trial
March 31, 2025
Pause in Trading
March 30, 2025
US Autism Diagnostic Study Commences with First Child Tested
March 11, 2025
North Shore Pediatric Therapy in Chicago joins Study
February 9, 2025
Positive Outcome from FDA Pre-Submission Meeting
December 18, 2024
Amended BB1 to Participate in Monash Uni Autism/ADHD MAGNET
November 20, 2024
Large-Scale Study Validates Accuracy in Detecting Autism
November 18, 2024
BB1 to Participate in Monash Uni Autism/ADHD MAGNET Project
November 12, 2024
BB1 Signs Partnership for Clinical Trial with Euro INTER-PSY
September 11, 2024
2024 Annual Report & Appendix 4E
August 28, 2024
BlinkLab Partners with Mental Care Group in Europe
July 29, 2024